Consistent with this, EBV infection was detected in COVID-19 patients, associated with increased risk of severe COVID-19 symptoms and fatal outcome (Roncati et al., 2020; Chen et al., 2021), and correlated increased levels of IL-6 (Lehner et al., 2020). This evidence concerns the gene IL6 and Epstein-Barr virus infection.